Literature DB >> 15031285

A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine. Contamination with bacterial outer membrane proteins.

Hisako Furukawa1, Katsumi Doh-ura, Ryo Okuwaki, Susumu Shirabe, Kazuo Yamamoto, Heiichiro Udono, Takashi Ito, Shigeru Katamine, Masami Niwa.   

Abstract

Because a definite diagnosis of prion diseases relies on the detection of the abnormal isoform of prion protein (PrPSc), it has been urgently necessary to establish a non-invasive diagnostic test to detect PrPSc in human prion diseases. To evaluate diagnostic usefulness and reliability of the detection of protease-resistant prion protein in urine, we extensively analyzed proteinase K (PK)-resistant proteins in patients affected with prion diseases and control subjects by Western blot, a coupled liquid chromatography and mass spectrometry analysis, and N-terminal sequence analysis. The PK-resistant signal migrating around 32 kDa previously reported by Shaked et al. (Shaked, G. M., Shaked, Y., Kariv-Inbal, Z., Halimi, M., Avraham, I., and Gabizon, R. (2001) J. Biol. Chem. 276, 31479-31482) was not observed in this study. Instead, discrete protein bands with an apparent molecular mass of approximately 37 kDa were detected in the urine of many patients affected with prion diseases and two diseased controls. Although these proteins also gave strong signals in the Western blot using a variety of anti-PrP antibodies as a primary antibody, we found that the signals were still detectable by incubation of secondary antibodies alone, i.e. in the absence of the primary anti-PrP antibodies. Mass spectrometry and N-terminal protein sequencing analysis revealed that the majority of the PK-resistant 37-kDa proteins in the urine of patients were outer membrane proteins (OMPs) of the Enterobacterial species. OMPs isolated from these bacteria were resistant to PK and the PK-resistant OMPs from the Enterobacterial species migrated around 37 kDa on SDS-PAGE. Furthermore, nonspecific binding of OMPs to antibodies could be mistaken for PrPSc. These findings caution that bacterial contamination can affect the immunological detection of prion protein. Therefore, the presence of Enterobacterial species should be excluded in the immunological tests for PrPSc in clinical samples, in particular, urine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031285     DOI: 10.1074/jbc.M400187200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Characterization of the prion protein in human urine.

Authors:  Ayuna Dagdanova; Serguei Ilchenko; Silvio Notari; Qiwei Yang; Mark E Obrenovich; Kristen Hatcher; Peter McAnulty; Lequn Huang; Wenquan Zou; Qingzhong Kong; Pierluigi Gambetti; Shu G Chen
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

Review 2.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

3.  Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease.

Authors:  Richard Rubenstein; Binggong Chang; Perry Gray; Martin Piltch; Marie S Bulgin; Sharon Sorensen-Melson; Michael W Miller
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

4.  Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease.

Authors:  Beiru Zhang; Yumi Une; Xiaoying Fu; Jingmin Yan; FengXia Ge; Junjie Yao; Jinko Sawashita; Masayuki Mori; Hiroshi Tomozawa; Fuyuki Kametani; Keiichi Higuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

5.  Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases.

Authors:  Reza Dabaghian; Inga Zerr; Uta Heinemann; Gianluigi Zanusso
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

6.  Persistence of pathogenic prion protein during simulated wastewater treatment processes.

Authors:  Glen T Hinckley; Christopher J Johnson; Kurt H Jacobson; Christian Bartholomay; Katherine D McMahon; Debbie McKenzie; Judd M Aiken; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2008-07-15       Impact factor: 9.028

7.  Assessing prion infectivity of human urine in sporadic Creutzfeldt-Jakob disease.

Authors:  Silvio Notari; Liuting Qing; Maurizio Pocchiari; Ayuna Dagdanova; Kristin Hatcher; Arend Dogterom; Jose F Groisman; Ib Bo Lumholtz; Maria Puopolo; Corinne Lasmezas; Shu G Chen; Qingzhong Kong; Pierluigi Gambetti
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

8.  The identification of disease-induced biomarkers in the urine of BSE infected cattle.

Authors:  Sharon L R Simon; Lise Lamoureux; Margot Plews; Michael Stobart; Jillian LeMaistre; Ute Ziegler; Catherine Graham; Stefanie Czub; Martin Groschup; J David Knox
Journal:  Proteome Sci       Date:  2008-09-05       Impact factor: 2.480

Review 9.  Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases.

Authors:  Hasier Eraña; Jorge M Charco; Ezequiel González-Miranda; Sandra García-Martínez; Rafael López-Moreno; Miguel A Pérez-Castro; Carlos M Díaz-Domínguez; Adrián García-Salvador; Joaquín Castilla
Journal:  Biomolecules       Date:  2020-03-19

Review 10.  PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease.

Authors:  Giorgio Giaccone; Fabio Moda
Journal:  Biomolecules       Date:  2020-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.